HK1220458A1 - 化合物之多晶型物及鹽 - Google Patents

化合物之多晶型物及鹽

Info

Publication number
HK1220458A1
HK1220458A1 HK16108550.7A HK16108550A HK1220458A1 HK 1220458 A1 HK1220458 A1 HK 1220458A1 HK 16108550 A HK16108550 A HK 16108550A HK 1220458 A1 HK1220458 A1 HK 1220458A1
Authority
HK
Hong Kong
Prior art keywords
polymorphs
salts
compound
Prior art date
Application number
HK16108550.7A
Other languages
English (en)
Inventor
Patricia Oliver
Original Assignee
Forum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forum Pharmaceuticals Inc filed Critical Forum Pharmaceuticals Inc
Publication of HK1220458A1 publication Critical patent/HK1220458A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
HK16108550.7A 2013-03-14 2016-07-19 化合物之多晶型物及鹽 HK1220458A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361785692P 2013-03-14 2013-03-14
PCT/US2014/026988 WO2014152135A1 (en) 2013-03-14 2014-03-14 Polymorphs and salts of a compound

Publications (1)

Publication Number Publication Date
HK1220458A1 true HK1220458A1 (zh) 2017-05-05

Family

ID=51581126

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108550.7A HK1220458A1 (zh) 2013-03-14 2016-07-19 化合物之多晶型物及鹽

Country Status (13)

Country Link
US (1) US20160002250A1 (zh)
EP (1) EP2970245A4 (zh)
JP (1) JP2016513676A (zh)
KR (1) KR20150126884A (zh)
CN (1) CN105358557A (zh)
AU (1) AU2014240130A1 (zh)
BR (1) BR112015022806A2 (zh)
CA (1) CA2906073A1 (zh)
HK (1) HK1220458A1 (zh)
IL (1) IL241495A0 (zh)
MX (1) MX2015012459A (zh)
TW (1) TW201512201A (zh)
WO (1) WO2014152135A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI634114B (zh) * 2013-05-08 2018-09-01 永恒生物科技公司 作為激酶抑制劑之呋喃酮化合物
WO2017079678A1 (en) * 2015-11-04 2017-05-11 Omeros Corporation Solid state forms of a pde10 inhibitor
MX2020008326A (es) * 2018-02-07 2020-09-28 Reata Pharmaceuticals Inc Formas de co-cristales de un analogo de novobiocina y prolina.
CN113125500B (zh) * 2021-04-21 2022-04-15 大连理工大学 一种跨尺度的含水合物多孔介质热导率的计算方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1123936B1 (en) * 1998-10-21 2003-12-10 Takeda Chemical Industries, Ltd. Fused pyridazine derivatives, process for the preparation of the same and uses thereof
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
MX2011000175A (es) * 2008-06-25 2011-06-27 Envivo Pharmaceuticals Inc Compuestos heterociclicos 1,2-di-substituidos.
AU2009345802B2 (en) * 2009-05-07 2016-05-26 Forum Pharmaceuticals Inc. Phenoxymethyl heterocyclic compounds
US20120220581A1 (en) * 2009-10-30 2012-08-30 Janssen-Cilag, S.A. IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
WO2011062194A1 (ja) * 2009-11-18 2011-05-26 武田薬品工業株式会社 アミノピリジン誘導体
WO2012083105A1 (en) * 2010-12-17 2012-06-21 Cocrystal Discovery, Inc. Inhibitors of hepatitis c virus polymerase

Also Published As

Publication number Publication date
US20160002250A1 (en) 2016-01-07
TW201512201A (zh) 2015-04-01
EP2970245A1 (en) 2016-01-20
MX2015012459A (es) 2016-05-09
AU2014240130A1 (en) 2015-10-08
WO2014152135A1 (en) 2014-09-25
BR112015022806A2 (pt) 2017-07-18
CN105358557A (zh) 2016-02-24
EP2970245A4 (en) 2016-10-19
KR20150126884A (ko) 2015-11-13
JP2016513676A (ja) 2016-05-16
IL241495A0 (en) 2015-11-30
CA2906073A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
IL245865A0 (en) Form i of crystalline ibrutinib
EP2970081A4 (en) SALTS OF TREPROSTINIL
EP2943901A4 (en) APPLICATION FOR MONITORING A PROPERTY OF A SURFACE
TWD174480S (zh) 耳機之部分
HK1226347A1 (zh) Aramchol鹽
PL3008039T3 (pl) Krystaliczna postać inhibitora mdm2
TWD174479S (zh) 耳機之部分
ZA201702252B (en) A selective inhibitor of prosphatidylinositol 3-kinase-gamma
GB201319277D0 (en) A new class of inducers of antimicrobial compounds
IL245357B (en) Amine salts of a prostacyclin analog
TWM476754U (en) Fillet set capable of winding tape
EP3023416A4 (en) PREPARATION OF (-) - HUPERZINE A
HK1220458A1 (zh) 化合物之多晶型物及鹽
HK1220187A1 (zh) 抗焦慮化合物的晶型
HK1211294A1 (zh) 取代的吡咯烷- -甲酰胺的不對稱合成
HK1223068A1 (zh) 種構建軟管的方法
ZA201607107B (en) Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound
HK1208864A1 (zh) 種海鞘碱- 中間體的製備方法
SG2013067434A (en) A method of moving teeth
GB201317022D0 (en) Polymorphs
HK1217700A1 (zh) 多晶型物形式
GB201312459D0 (en) A New Design of a Toothbrush
GB201303572D0 (en) New Compound